GMP vs ISO 22301
GMP
Regulatory framework ensuring consistent pharmaceutical manufacturing quality
ISO 22301
International standard for business continuity management systems.
Quick Verdict
GMP ensures manufacturing quality and safety in pharma via preventive controls and inspections, while ISO 22301 builds business continuity resilience across sectors through BIA and testing. Companies adopt GMP for regulatory compliance and patient protection; ISO 22301 for disruption recovery and stakeholder trust.
GMP
Good Manufacturing Practice (GMP)
Key Features
- Mandates preventive controls beyond final product testing
- Requires independent quality unit for batch approval
- Integrates risk-based Quality Risk Management principles
- Enforces process validation and equipment qualification
- Demands rigorous documentation and data integrity
ISO 22301
ISO 22301:2019 Business continuity management systems
Key Features
- PDCA cycle for continual BCMS improvement
- Business Impact Analysis (BIA) and risk assessment
- Leadership commitment with policy and roles
- Operational testing of recovery strategies
- Annex SL integration with ISO 27001
Detailed Analysis
A comprehensive look at the specific requirements, scope, and impact of each standard.
GMP Details
What It Is
Good Manufacturing Practice (GMP) is a regulatory framework of minimum enforceable standards for manufacturing pharmaceuticals, biologics, and related products. It ensures products are consistently produced to meet quality, safety, and purity criteria through preventive controls spanning facilities, equipment, processes, personnel, and records. Key approach is risk-based via Quality Risk Management (QRM), emphasizing design-in quality over end-testing.
Key Components
- Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)
- Elements include quality systems (PQS per ICH Q10), validation, documentation (ALCOA++), CAPA, supplier controls, and audits
- Built on ICH Q9/Q10, FDA 21 CFR 210/211, EU EudraLex Vol. 4, WHO GMP
- Compliance via inspections, no central certification but enforceable regionally
Why Organizations Use It
Mandated for market access; prevents recalls, contamination, liability. Drives efficiency, supply reliability, patient protection. Builds regulator trust, reduces remediation costs, enables global trade via harmonization (PIC/S, MRAs).
Implementation Overview
Phased: gap analysis, VMP, validation (DQ/IQ/OQ/PQ), training, audits. Applies to pharma/biologics manufacturers globally; scales by size/risk. Ongoing via internal audits, management review.
ISO 22301 Details
What It Is
ISO 22301:2019 is the international certification standard for Business Continuity Management Systems (BCMS). It establishes requirements to plan, implement, monitor, and improve resilience against disruptions like cyberattacks, pandemics, and natural disasters using a PDCA (Plan-Do-Check-Act) cycle and risk-based approach.
Key Components
- 10 clauses (4-10 core): context, leadership, planning (BIA, risk assessment), support, operations (recovery strategies, testing), evaluation (audits, reviews), improvement.
- No prescriptive controls; flexible, tailored to organization.
- Built on Annex SL for integration with ISO 27001, 31000.
- 3-year certification with annual surveillance audits.
Why Organizations Use It
- Mitigates downtime, financial losses; enhances recovery (e.g., RTOs).
- Meets regulations (NIS, NIST); builds stakeholder trust, reputation.
- Provides competitive edges, lower insurance, procurement advantages.
- Fosters proactive resilience culture amid rising global risks.
Implementation Overview
- Phased: gap analysis, BIA, documentation, training, testing, audits.
- 60 days to 6 months typical; suits all sizes/sectors.
- Two-stage certification (readiness, effectiveness); tools accelerate.
Key Differences
| Aspect | GMP | ISO 22301 |
|---|---|---|
| Scope | Manufacturing controls for product quality/safety | Business continuity management system resilience |
| Industry | Pharma, biologics, food, cosmetics globally | All sectors worldwide, any organization size |
| Nature | Enforceable regulations with inspections | Voluntary certification standard |
| Testing | Process/equipment validation, audits | BIA, exercises, internal/external audits |
| Penalties | Warning letters, recalls, fines | Loss of certification, no legal penalties |
Scope
Industry
Nature
Testing
Penalties
Frequently Asked Questions
Common questions about GMP and ISO 22301
GMP FAQ
ISO 22301 FAQ
You Might also be Interested in These Articles...
Cyber Essentials on a Shoestring: Filling the Microsoft 365 Security Gaps with Free and Low-Cost Tools
Close Cyber Essentials 2026 gaps in basic Microsoft 365 plans using free and low-cost tools. Achieve MFA, patching, and audit readiness without enterprise spend
ISO 27701 Implementation Roadmap: Step-by-Step Guide for Extending Your ISO 27001 ISMS to PIMS
Extend ISO 27001 ISMS to ISO 27701 PIMS with this step-by-step roadmap. Master role-specific controls, avoid pitfalls, meet certification evidence needs for pri
Using CIS Controls v8.1 as a ‘Compliance On-Ramp’: Map One Security Program to NIST CSF, ISO 27001, PCI DSS, and NIS2
Use CIS Controls v8.1 as your compliance on-ramp. Map one security program to NIST CSF, ISO 27001, PCI DSS, and NIS2 without duplicating work via practical mapp
Run Maturity Assessments with GRADUM
Transform your compliance journey with our AI-powered assessment platform
Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.
Explore More Comparisons
See how GMP and ISO 22301 compare against other standards